Drug Categorya | USC Category | Brand Name | |
---|---|---|---|
DPP-4 inhibitors | 39261/39262 | • Janumet/Janumet XR | • Kombiglyze XR |
• Januvia | • Onglyza | ||
• Juvisync | • Tradjenta | ||
GLP-1 receptor agonists | 39251 | • Bydureon | • Victoza |
• Byetta | |||
Basal insulin | 39133 | • Lantus/Lantus SoloSTAR | • Insulatard NPH Human |
• Levemir/Levemir FlexPen/Levemir FlexTouch | |||
Rapid-acting insulin | 39131 | • Apidra/Apidra SoloSTAR | • Novolin |
• Humalog/Humalog KwikPen | • Novlog | ||
• Humalog Mix | • Relion | ||
• Humalin | • Velosulin | ||
• Mixtard |
a Combination formulations of medications within these categories have been rolled up under the primary active component, e.g., Janumet is rolled up under Januvia within the DPP-4 inhibitor category.
DPP-4 = dipeptidyl peptidase-4; GLP-1 = glucagon-like peptide-1; USC = Uniform System of Classification.